STOCKS TELEGRAPH

Tag: IBIO

  • IBIO Stocks Rally Amid Game-Changing AI Drug Discovery Deal

    IBIO Stocks Rally Amid Game-Changing AI Drug Discovery Deal

    iBio, Inc. (NYSE: IBIO) shares are experiencing a substantial surge of 127.83% this morning on the US stock market. At the latest check during the current session, IBIO shares were trading up at $2.62. This uptick in IBIO shares follows the announcement of a groundbreaking collaboration in AI-driven drug discovery.

    Today, iBio Inc. (IBIO) has disclosed its collaboration agreement with AstralBio, Inc. This collaboration aims to discover, engineer, and develop innovative antibodies targeting obesity and other cardiometabolic disorders.

    The objective of this transformative partnership is to swiftly establish an exceptional cardiometabolic disease portfolio by leveraging iBio’s proficiency in creating antibodies for challenging targets, combined with AstralBio’s extensive experience in biologics and drug development.

    Under this agreement, iBio has exclusively licensed its AI-powered technology to identify and engineer four targets for treating cardiometabolic diseases, with AstralBio responsible for advancing candidates through pre-clinical development to Investigational New Drug (IND) application stage.

    Additionally, iBio holds the exclusive option to license three cardiometabolic targets from AstralBio, with rights for development, manufacturing, and commercialization upon exercising this option.

    Consequently, iBio and AstralBio are commencing the development of a lead program targeting the transforming growth factor beta (TGFb) superfamily for addressing muscle wasting and obesity.

    The collaboration may also be expanded to include further targets in various fields by mutual agreement. IBIO expresses confidence in the potential of AI-enabled technology to develop antibodies against challenging targets in the cardiometabolic domain.

    The company envisions the future of treating millions affected by obesity and cardiometabolic diseases globally through next-generation therapies that improve both efficacy and tolerability profiles compared to current treatments.

    Notably, the lead program targeting the TGFb superfamily aims to achieve a best-in-class profile. IBIO anticipates announcing additional novel targets promising similarly transformative outcomes in the coming months.

    Furthermore, in an equity transaction, IBIO yesterday concluded a $15 million private placement financing with ADAR1 Capital Management, Lynx1 Capital Management, Ikarian Capital, and other institutional investors.

    A portion of the net proceeds will be allocated to supporting new partnerships, such as the collaboration with AstralBio.

  • iBio, Inc. (IBIO) stock Collapse After Hours Following Fiscal Q2 2022 Results

    On February 14, iBio, Inc. (IBIO) declared its financial results for the fiscal second quarter of 2022, which ended December 31, 2021. Consequently, the stock took a hit in the after-hours and plunged down.

    It seems investors were hoping for a better result as the stock added 4.75% on positive anticipation during the regular trading. The volume of the day remained slightly above the average at 4.14 million shares. At the close of the regular session, IBIO stock had a value of $0.39 per share. Following the announcement of the results, the stock plunged down to $0.36 per share in the after hours. Shattering investors’ hopes, IBIO lost 7.81% in the after-hours on Monday.

    The biotechnology company, iBio, Inc. was founded in 1993 and is based in Bryan, TX. Currently, its 217.96 million outstanding shares trade at a market capitalization of $81.23 million. IBIO stock has declined by 28.89% year to date while it subtracted 83.87% last year.

    IBIO’s Fiscal Q2 2022

    In the fiscal Q2 2022, the company generated $0.2 million in revenues, against $0.7 million in the year-ago period. Thus, the company’s revenues declined by 76% YOY.

    Moreover, the consolidated net loss for the fiscal Q2 2022 was $11.9 million, against $8.2 million in the same quarter of last the previous year. Therefore, the net loss per basic and diluted share was $0.05 and $0.04 in fiscal Q2 2022 and 2021, respectively.

    IBIO ended the quarter with cash, cash equivalents, and debt securities of $57.4 million, which excludes restricted cash o $5.9 million.

    The company expects that this would be enough for its cash runway through September 30, 2023.

    Covid-19 Vaccine Program Updates

    On January 26, the company provided updates on IBIO-202, its lead Covid-19 vaccine program. Recently, the company received FDA’s response to its pre-investigational new drug package for IBIO-202. As per the FDA’s feedback, the company plans to commence the IND-enabling challenge studies for the second-generation vaccine candidate. Furthermore, the company intends to file an IND application with the FDA before the end of 2022.

    IBIO-202

    IBIO-202 is a second-generation vaccines candidate that targets nucleocapsid (N) protein. Currently, the commercially available first-gen vaccines target the S protein and require repeated booster doses. According to WHO, such vaccines with continuous booster dose requirements are not a sustainable solution. Additionally, evidence has shown N reactive T cells to play a protective role rather than S.

  • IBIO Stock Declining After a Hefty Monday, Here’s the Reason

    iBio, Inc. (IBIO), a biotechnology company, has declined 3.94% in aftermarket trading session. Consequently, IBIO is trading at $0.82 at the time of the writing. The decline could be attributed to the profit-taking factor after the stock closed Monday’s regular trading session at $0.85, surging 29.15% during the day. The surge came after the company announced an update regarding its lead COVID-19 vaccine program.

    Why IBIO Surged?

    On Monday, IBIO announced the update about IBIO-202, the lead COVID-19 vaccine program of the company. The update has come in light of the emergence of the new variant of COVID, namely Omicron (B.1.1.529). The company said that it believes the N-protein present in the vaccine could serve to help overcome the effects of COVID-19. The N-protein could represent an important target for the next generation of vaccines because it’s highly conserved than S-protein. Also, it appears to be significantly more effective than the S protein in stimulating antibody-dependent natural killer cell activation.

    Q1 2022 Operational Results

    On 15th November, IBIO released the operational and financial results for the first quarter of the fiscal year 2022. The quarter ended on 30th September 2021. The company had cash and cash equivalents of $62.82 million on 30th September. The total revenue generated by the company during the period was $211,000 against $410,000 during the same period of fiscal 2021. The total operating expenses for the quarter were $9.14 million against $7.22 million for the same quarter of fiscal 2021. The consolidated net loss suffered by the company during the period was $8.94 million (or $0.04 per basic and diluted share) against $7.53 million (or $0.05 per basic and diluted share) for the same period of fiscal 2021.

    Executive Commentary

    Tom Isett, Chairman & CEO of IBIO, while commenting on the results said that the company is continuing to execute the growth strategy as it is starting the fiscal year 2022. He said that the company is confident its investment over the past year in talent, technology, and infrastructure will return value to patients and shareholders as it goes forward.

    Future Outlook for IBIO

    The last month has seen IBIO stock increase more than 7%. But as we start looking toward older stats, the picture looks bleaker for IBIO. This depicts that the performance of IBIO stock has markedly improved during the recent past, particularly due to the positive sentiments in form of developments related to IBIO-202. Going forward, investors should keep a close eye on the performance of IBIO stock.

  • What Caused IBIO Stock To Rise After Hours?

    What Caused IBIO Stock To Rise After Hours?

    At last check, shares of biotech innovator and biologics contract manufacturing organization iBio Inc. (IBIO) were up 7.19% to $1.49 in after-hours trading. Thursday’s closing price for IBIO stock was $1.39, up 4.51% from the previous day’s close. IBIO stock volume on the day was reduced to 6.36 million shares from 12.29 million shares in the past 50 days. Three new antibody programs support the company’s oncology drug discovery pipeline, driving IBIO stock higher.

    What program has IBIO started?

    iBio is a global leader in plant-based biologic production. In iBio’s FastPharming System, automated hydroponics, and novel glycosylation technologies are combined to produce monoclonal antibodies, vaccines, bioinks, and other proteins. iBio is developing biopharmaceuticals that treat cancers, as well as fibrotic and infectious diseases. iBio CDMO LLC, a subsidiary of the Company, provides Contract Development and Manufacturing Services to the FastPharming business, as well as Glycaneering services related to recombinant protein design.

    Announcing the addition of three anticancer targets to its pipeline of potential therapeutics, iBio, Inc. has taken another significant step towards harnessing the speed and throughput of its proprietary, plant-based FastPharming Protein Expression System.

    • With this enhancement, IBIO expands on its new drug discovery capabilities announced just a few weeks ago.
    • By partnering with best-in-class technology providers, IBIO intends to create the FastPharming System that will reduce the time and cost to move from initial concept to clinic, which will be part of its efforts to redefine the drug development paradigm.
    • FairJourney Biologics SA (“FairJourney”), a leader in antibody optimization, has agreed to provide research services to IBIO.
    • The deal provides IBIO with access to a proprietary antibody library and novel display technologies.
    • By combining its ‘speed-to-clinic’ advantages along with Glycaneering Technologies and FairJourney’s antibody optimization technologies, IBIO may be able to rapidly develop differentiated cancer therapeutic antibodies that will be more effective against cancer cells.
    • Several undisclosed IBIO collaborations are advancing rapidly towards the clinic as a result of its antibody discovery expertise in oncology.
    • The glycosylation techniques IBIO uses to enhance human anti-cancer antibody development will enable IBIO to change the bioprocess paradigm.

    What has IBIO accomplished?

    To complement the company’s previously offered contract development and manufacturing services, IBIO is adding its own in-house drug discovery capabilities. As a result of its plant-based FastPharming System, IBIO continues to reduce the lag times and costs associated with pharmaceutical development, and at the same time, to help develop its own biopharmaceuticals to address unmet medical needs in human health and veterinary medicine.

  • 15 Trending Stocks in Biotechnology Industry

    15 Trending Stocks in Biotechnology Industry

    This year, biotech companies on the stock exchange have skyrocketed. This is no surprise since biotech firms are the leaders in the battle against the coronavirus pandemic. Even with Pfizer’s first vaccine in the UK, investors and pharmaceutical companies are well aware that the race is far ahead.
    Other diseases should not be ignored apart from coronavirus vaccines. The biotech sector is also creating headlines and innovating in areas linked to dementia, cancer, hereditary disorders, etc. Given the above, buyers are probably faced with the difficulty of choosing the best ones to purchase.

    Curis Inc. (NASDAQ:CRIS) shares were trading up 354.86% at $6.55 at the time of writing on Tuesday following announcement of proposed public offering of common stock.

    Curis Inc. (NASDAQ:CRIS) share price went from a low point around $0.62 to briefly over $3.59 in past 52 weeks, though shares have since pulled back to $6.55. CRIS market cap has remained high, hitting $409.70M at the time of writing, giving it price-to-sales ratio of more than 30.

    If we look at the recent analyst rating CRIS, Laidlaw initiated coverage on CRISshares with a Buy rating.

    Lexicon Pharmaceuticals Inc. (LXRX) last closed at $3.08, in a 52-week range of $1.03 to $5.33. Analysts have a consensus price target of $2.37. On November 17, 2020, the firmreported that both the SOLOIST and SCORED Phase 3 studies achieved their primary endpoints by demonstrating statistically significant reductions in total cardiovascular deaths, hospitalizations for heart failure and urgent heart failure visits in patients treated with sotagliflozin as compared with placebo.

    IGM Biosciences Inc. (IGMS) stock soar by 57.75% to $115.03 after declaringpricing of upsized $200 million public offering. The most recent rating by Robert W. Baird, on July 17, 2020, is at an Outperform.

    Infinity Pharmaceuticals Inc. (NASDAQ:INFI) Shares headed rising, higher as much as 29.44%. The company will hold a conference call on Wednesday, December 9, 2020 at 10:00 a.m. ET to discuss clinical data from ongoing studies evaluating eganelisib in triple negative breast cancer (TNBC) The most recent rating by Oppenheimer, on June 27, 2019, is at an Outperform.

    Oncternal Therapeutics Inc. (NASDAQ:ONCT) rose 27.64% after gaining more than $1.1 on Tuesday after reporting updated interim clinical data from the ongoing Phase 1/2 CIRLL (Cirmtuzumab and Ibrutinib targeting ROR1 for Leukemia and Lymphoma) clinical trial.

    Proteostasis Therapeutics Inc. (PTI) last closed at $1.23, in a 52-week range of $0.87 to $4.72. The firm reported on November 16, 2020. a net loss of approximately $8.2 million for the three months ended September 30, 2020, as compared to a net loss of $12.8 million for the same period in the prior year.

    InflaRx N.V. (IFRX) stock soar by 18.27% to $4.79. The most recent rating by SVB Leerink, on November 06, 2020, is at an Outperform.

    Syros Pharmaceuticals Inc. (NASDAQ:SYRS) Shares headed rising, higher as much as 17.47% after closing $90.5 million strategic financing. The most recent rating by H.C. Wainwright, on November 04, 2020, is at a Buy.

    Aerpio Pharmaceuticals Inc. (NASDAQ:ARPO) rose 16.28% after gaining more than $0.28 on Tuesday.

    Ampio Pharmaceuticals Inc. (AMPE) last closed at $1.35, in a 52-week range of $0.31 to $1.39. The firm recently revealed that it will conduct its annual meeting in a virtual format only on December 12, 2020 at 9:00 am MST.

    Regulus Therapeutics Inc. (RGLS)stock soar by 15.19% to $0.93 following the closing of $19.4 million private placement of equity. The most recent rating by B. Riley FBR Inc., on March 28, 2018, is at a Neutral.

    Cancer Genetics Inc. (NASDAQ:CGIX) Shares headed rising, higher as much as 14.79%. The most recent rating by Maxim Group, on December 07, 2017, is at a Buy.

    Marinus Pharmaceuticals Inc. (NASDAQ:MRNS) fall -11.85% after losing more than -$1.85 on Tuesday. The healthcare firm lately declared pricing of $70 million public offering of common stock, which is expected to close on or about December 10, 2020.

    iBio Inc. (IBIO) last closed at $1.31, in a 52-week range of $0.19 to $7.45 after declaring pricing of $35 million public offering of common stock. Analysts have a consensus price target of $2.00.

    Vaccinex Inc. (VCNX) stock soar by 14.08% to $2.35. The most recent rating by BTIG Research, on September 23, 2020, is at a Neutral.

  • Market Movers: What changed for these 45 stocks while you were sleeping

    Market Movers: What changed for these 45 stocks while you were sleeping

    Sundial Growers Inc. (SNDL) stock plunged -11.07% to $0.466 in the pre-market trading. The firm recently reported that it filed new shelf registration statement. The most recent rating by CIBC, on August 17, 2020, is a Neutral.
    Obalon Therapeutics Inc. (NASDAQ: OBLN) shares are trading down -10.87% at $2.05 at the time of writing. Company’s 52-week ranged between $0.62 to $2.14. Analysts have a consensus price target of $3.
    Eastman Kodak Company (KODK) stock moved up 7.14 percent to $12.9 in the pre-market trading after the company gets a clean chit from the U.S. government.
    American Airlines Group Inc. (AAL), a Airlines company, rose about 2.03% at $17.56 in pre-market trading Tuesday.
    Zomedica Corp. (ZOM) gained over 2.45% at $0.18 in pre-market trading Tuesday December 08, 2020 after reporting that, with the hiring of Debra Rock to lead the Company’s Marketing Department, its internal commercial leadership team is complete.
    Before the trading started on December 08, 2020, Tesla Inc. (TSLA) is down -0.35% to reach $639.5. It has been trading in a 52-week range of $65.45 to $607.80.
    Nano Dimension Ltd. (NNDM) is up more than 8.55% at $7.24 in pre-market hours Tuesday December 08, 2020 following the declaration of its Pricing $180 million registered direct offering. The stock had dropped over -10.35% to $6.67 in the last trading session.
    Apex Technology Acquisition Corporation (NASDAQ: APXT) shares are trading up 4.31% at $15.25 at the time of writing. Company’s 52-week ranged between $9.13 to $17.25.
    FuelCell Energy Inc. (FCEL) stock soared 2.55% to $8.03 in the pre-market trading. The firm recently reported completion of the previously announced underwritten public offering of 39,696,320 shares of its common stock. The most recent rating by JP Morgan, on November 19, 2020, is a Neutral.
    RMG Acquisition Corp. (RMG) gained over 3.24% at $17.2 in pre-market trading Tuesday December 08, 2020.
    BlackBerry Limited (NYSE: BB) shares are trading up 4.24% at $8.6 at the time of writing. The AI security provider recently declared that it will report results for the third quarter of fiscal year 2021 at 5:30 p.m. ET on Thursday, December 17, 2020. The Company’s 52-week ranged between $2.70 to $9.69.
    Kaixin Auto Holdings (KXIN) is up more than 6.9% at $4.65 in pre-market hours Tuesday December 08, 2020. The stock had dropped over -11.22% to $4.35 in the last trading session.
    XPeng Inc. (XPEV) gained over 2.19% at $49.36 in pre-market trading Tuesday December 08, 2020 after declaring that it intends to offer and sell 40,000,000 American Depositary Shares.
    Ideanomics Inc. (IDEX) is up more than 9.66% at $2.27 in pre-market hours Tuesday December 08, 2020. The stock had jumped over 2.48% to $2.07 in the last trading session.
    HEXO Corp. (HEXO) stock plunged -4.95% to $0.96 in the pre-market trading following the proclamation of downward revision to its proposed share consolidation ratio. The most recent rating by Cantor Fitzgerald, on July 22, 2020, is a Neutral.
    Before the trading started on December 08, 2020, Li Auto Inc. (LI) is up 3.21% to reach $32.5. It has been trading in a 52-week range of $14.31 to $47.70.
    Kandi Technologies Group Inc. (NASDAQ: KNDI) shares are trading up 7.18% at $9.1 at the time of writing. The firm recently issued chairman’s letter to shareholders. Company’s 52-week ranged between $2.17 to $17.45.
    Virgin Galactic Holdings Inc. (SPCE), a Aerospace & Defense company, rose about 6.12% at $35.87 in pre-market trading Tuesday.
    Moderna Inc. (MRNA) grew over 3.44% at $165.01 in pre-market trading today after reporting that Canada exercises increased option for total of 40 million doses of mRNA vaccine candidate against COVID-19 (mRNA-1273).
    Platinum Group Metals Ltd. (PLG) is up more than 17.21% at $4.7 in pre-market hours Tuesday December 08, 2020. The stock had jumped over 29.35% to $4.01 in the last trading session.
    United Microelectronics Corporation (NYSE: UMC) shares are trading up 1.22% at $9.15 at the time of writing following the declaration of its unaudited net sales for the month of November 2020. Company’s 52-week ranged between $2.10 to $8.96.
    Energy Fuels Inc. (UUUU) stock soared 6.32% to $3.03 in the pre-market trading. The most recent rating by Noble Capital Markets, on May 13, 2019, is a Market perform.
    ToughBuilt Industries Inc. (TBLT), a Tools & Accessories company, dropped about -10.84% at $0.7356 in pre-market trading Tuesday after reporting the launch 14 new tool organization SKUs at LOWE’S nationwide.
    IZEA Worldwide Inc. (NASDAQ: IZEA) shares are trading down -6.68% at $0.885 at the time of writing. Company’s 52-week ranged between $0.07 to $3.13.
    Gran Tierra Energy Inc. (GTE) gained over 64.15% at $0.5 in pre-market trading Tuesday December 08, 2020 following the publication of a financial update and the Company’s 2021 capital budget and production guidance.
    Electrameccanica Vehicles Corp. (SOLO) gained over 4.15% at $7.78 in pre-market trading Tuesday December 08, 2020.
    Before the trading started on December 08, 2020, iBio Inc. (IBIO) is down -8.67% to reach $1.37 after revealing an underwritten public offering of its common stock. It has been trading in a 52-week range of $0.19 to $7.45.
    Cinedigm Corp. (CIDM) is down more than -2.34% at $0.671 in pre-market hours Tuesday December 08, 2020. The stock had dropped over -1.63% to $0.69 in the last trading session.
    CBAK Energy Technology Inc. (CBAT), a Electrical Equipment & Parts company, rose about 8.98% at $7.04 in pre-market trading Tuesday after declaring that its wholly owned subsidiary, Dalian CBAK Energy Technology Co., LTD signed a joint development agreement with Wuxi Lead Intelligent Equipment Co., Ltd..
    Before the trading started on December 08, 2020, Torchlight Energy Resources Inc. (TRCH) is up 2.99% to reach $0.69. It has been trading in a 52-week range of $0.21 to $1.09.
    Before the trading started on December 08, 2020, Sumo Logic Inc. (SUMO) is up 5.43% to reach $26.0 after releasing financial results for the third quarter of its fiscal 2021, ended October 31, 2020. It has been trading in a 52-week range of $16.71 to $30.29.
    QEP Resources Inc. (QEP) is up more than 5.63% at $2.25 in pre-market hours Tuesday December 08, 2020. The stock had dropped over -1.39% to $2.13 in the last trading session.
    ON Semiconductor Corporation (NASDAQ: ON) shares are trading up 4.63% at $31.99 at the time of writing. The firm lately revealed that Hassane El-Khoury has been named as the company’s president, chief executive officer and member of its board of directors. Company’s 52-week ranged between $8.17 to $30.04.
    Uranium Energy Corp. (UEC) stock soared 11.89% to $1.6 in the pre-market trading. The most recent rating by Canaccord Genuity, on October 14, 2020, is a Speculative buy.
    Stitch Fix Inc. (SFIX) gained over 33.27% at $47.75 in pre-market trading Tuesday December 08, 2020 following the releaseof its financial results for the first quarter of fiscal year 2021 ended October 31, 2020
    Switchback Energy Acquisition Corporation (SBE) grew over 1.76% at $37.01 in pre-market trading today.
    Stealth BioTherapeutics Corp (MITO) is down more than -1.34% at $1.47 in pre-market hours Tuesday December 08, 2020 after announcing appointment of Eve E. Slater, M.D., F.A.C.C. to its Board of Directors. The stock had jumped over 14.62% to $1.49 in the last trading session.
    Gevo Inc. (GEVO) grew over 3.59% at $1.73 in pre-market trading today.
    Before the trading started on December 08, 2020, Trillium Therapeutics Inc. (TRIL) is down -5.29% to reach $14.51 after presenting at the American Society of Hematology (ASH) Annual Meeting, taking place virtually from December 5-8, 2020. It has been trading in a 52-week range of $0.29 to $20.96.
    Lizhi Inc. (LIZI) stock moved up 2.11 percent to $3.88 in the pre-market trading.
    Dare Bioscience Inc. (DARE) stock soared 5.26% to $1.4 in the pre-market trading after declaring positive topline results from DARE-BVFREE, a Phase 3 trial of DARE-BV1 in patients diagnosed with bacterial vaginosis.
    Top Ships Inc. (TOPS) gained over 6.04% at $1.58 in pre-market trading Tuesday December 08, 2020.
    Westwater Resources Inc. (WWR) grew over 1.37% at $5.94 in pre-market trading today following update on pilot plant operations provided by company.
    InterPrivate Acquisition Corp. (IPV) stock moved up 5.25 percent to $15.03 in the pre-market trading.
    Before the trading started on December 08, 2020, Futu Holdings Limited (FUTU) is up 2.41% to reach $43.31 following the announcement of agreement to purchase shares by a leading global investment firm. It has been trading in a 52-week range of $8.16 to $51.10.

  • iBio, Inc. (NYSEA: IBIO), shares drowned in the Premarket following offering of its common stock

    Today, In the premarket session, iBio, Inc. (NYSEA: IBIO), the stock dropped -10% to $1.35 after a biotechnology innovator, and biologics compounder announced today that it is issuing common stock in an underwritten public offering. Furthermore, iBio has granted the underwriter an option to purchase up to 15% additional shares in its public offering.

    Cantor Fitzgerald & Co. has agreed to act as the sole book-running manager for the offering.

    iBio plans to use the proceeds from the offering to accelerate the development of its biotherapeutic and vaccine candidates, license more biopharmaceutical assets, and to fund general corporate purposes. That includes, but is not limited to, investment in oncology, fibrotic, and infectious diseases and general corporate expenditures and working capital demands and acquisitions and business growth.

  • What changed for these 49 stocks in Pre Market Session

    What changed for these 49 stocks in Pre Market Session

    Lizhi Inc. (LIZI) stock plunged -8.14% to $4.4 in the pre-market trading after reporting that it entered in-car audio collaboration with Xpeng Motors. The most recent rating by Citigroup, on February 18, 2020, is a Buy.
    American Airlines Group Inc. (NASDAQ: AAL) shares are trading up 4.72% at $16.85 at the time of writing. Company’s 52-week ranged between $8.25 to $30.78.
    FuelCell Energy Inc. (FCEL) is up more than 5.01% at $7.75 in pre-market hours Friday December 04, 2020. The firm recently declared the pricing of its underwritten public offering of 34,518,539 shares of its common stock, at a public offering price of $6.50 per share. The stock had jumped over 1.93% to $7.38 in the last trading session.
    Before the trading started on December 04, 2020, AMC Entertainment Holdings Inc. (AMC) is up 5.51% to reach $3.83. It has been trading in a 52-week range of $1.95 to $8.78.
    Cinemark Holdings Inc. (CNK) stock soared 6.02% to $14.1 in the pre-market trading. The most recent rating by Loop Capital, on November 19, 2020, is a Hold.
    Iterum Therapeutics plc (ITRM), a Biotechnology company, dropped about -3.8% at $0.809 in pre-market trading Friday.
    Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) shares are trading up 3.7% at $26.36 at the time of writing following its announcement extension of suspension of voyages. Company’s 52-week ranged between $7.03 to $59.78. Analysts have a consensus price target of $26.
    Before the trading started on December 04, 2020, Jaguar Health Inc. (JAGX) is up 7.84% to reach $0.399. It has been trading in a 52-week range of $0.19 to $1.08.
    Transocean Ltd. (RIG), a Oil & Gas Drilling company, rose about 4.43% at $2.12 in pre-market trading Friday after declaring amendments to certain financing documents and internal reorganization transactions to resolve allegations contained in purported notices of default.
    Novan Inc. (NOVN) stock soared 19.92% to $0.67 in the pre-market trading. The most recent rating by Piper Jaffray, on January 06, 2020, is a Neutral.
    Li Auto Inc. (LI) lost over -2.48% at $31.51 in pre-market trading Friday December 04, 2020 following declaration its pricing of follow-on public offering of American depositary shares.
    Southwestern Energy Company (NYSE: SWN) shares are trading up 2.13% at $2.88 at the time of writing. Company’s 52-week ranged between $1.06 to $3.90. Analysts have a consensus price target of $2.40.
    Occidental Petroleum (OXY) is up more than 3.23% at $16.92 in pre-market hours Friday December 04, 2020. The company recently reported the release of its 2020 Climate Report, which provides a pathway detailing milestones to achieve its net-zero aspirations. The stock had jumped over 3.15% to $16.39 in the last trading session.
    Torchlight Energy Resources Inc. (TRCH) is up more than 6.9% at $0.48 in pre-market hours Friday December 04, 2020. The stock had jumped over 15.13% to $0.45 in the last trading session.
    TransGlobe Energy (TGA) grew over 2.82% at $0.659 in pre-market trading today following its agreement to merge, extend and modernize its eastern Desert concessions.
    Before the trading started on December 04, 2020, Catabasis Pharmaceuticals Inc. (CATB) is up 2.07% to reach $1.97. It has been trading in a 52-week range of $1.25 to $8.59.
    Inovio Pharmaceuticals Inc. (INO) stock moved up 8.07 percent to $13.53 in the pre-market trading after declaring the execution of an agreement with Kaneka Eurogentec S.A., for Eurogentec to manufacture INOVIO’s COVID-19 vaccine candidate INO-4800 at their industry-leading GMP plasmid production scales.
    Clovis Oncology Inc. (CLVS) is down more than -4.81% at $5.15 in pre-market hours Friday December 04, 2020. The stock had jumped over 11.09% to $5.41 in the last trading session.
    Cinedigm Corp. (CIDM) gained over 71.43% at $0.96 in pre-market trading Friday December 04, 2020 after reporting that its eight additional linear streaming channels are now Available on Rad’s fast-growing global streaming platform.
    Onconova Therapeutics Inc. (ONTX) stock plunged -1.9% to $0.3143 in the pre-market trading. The most recent rating by H.C. Wainwright, on March 01, 2018, is a Buy.
    Marvell Technology Group Ltd. (MRVL) stock plunged -5.1% to $43.2 in the pre-market trading after announcing a quarterly dividend of $0.06 per share of common stock payable on January 14, 2021 to shareholders of record as of December 23, 2020. The most recent rating by Craig Hallum, on October 30, 2020, is a Buy.
    QEP Resources Inc. (QEP) stock soared 5.0% to $2.1 in the pre-market trading. The most recent rating by JP Morgan, on July 20, 2020, is a Neutral.
    Arlo Technologies Inc. (NYSE: ARLO) shares are trading up 3.09% at $7.0 at the time of writing. The company recently revealed that Matthew McRae, CEO, and Gordon Mattingly, CFO, will present at the Raymond James Virtual Technology Investors Conference on Tuesday, December 8, 2020. Company’s 52-week ranged between $1.20 to $7.75. Analysts have a consensus price target of $6.
    Before the trading started on December 04, 2020, Nxt-ID Inc. (NXTD) is down -3.91% to reach $0.41. It has been trading in a 52-week range of $0.21 to $0.89.
    Halliburton Company (HAL) gained over 3.66% at $18.68 in pre-market trading Friday December 04, 2020 following its deal with Accenture (ACN), to accelerate Halliburton’s digital supply chain transformation and support digitalization within the Company’s manufacturing function.
    United Microelectronics (UMC) stock soared 10.32% to $8.55 in the pre-market trading. The most recent rating by Credit Suisse, on October 12, 2020, is an Outperform.
    Before the trading started on December 04, 2020, Cloudera Inc. (CLDR) is up 14.85% to reach $13.3 after reporting results for its third quarter of fiscal 2021, ended October 31, 2020. It has been trading in a 52-week range of $4.76 to $14.20.
    Before the trading started on December 04, 2020, Isoray Inc. (ISR) is down -4.92% to reach $0.47. It has been trading in a 52-week range of $0.35 to $1.06.
    iBio Inc. (AMEX: IBIO) shares are trading down -0.66% at $1.51 at the time of writing. The firm recently reported an agreement with Belgium-based ATB Therapeutics to produce its bioengineered antibody-toxin fusion proteins using iBio’s FastPharming® System. Company’s 52-week ranged between $0.14 to $7.45. Analysts have a consensus price target of $2.55.
    Centennial Resource Development Inc. (CDEV) stock soared 3.13% to $1.32 in the pre-market trading. The most recent rating by MKM Partners, on November 30, 2020, is a Neutral.
    BioCryst Pharmaceuticals Inc. (BCRX) is up more than 24.44% at $6.39 in pre-market hours Friday December 04, 2020 following the FDA Approval of ORLADEYO™ (berotralstat), First Oral, Once-daily Therapy to prevent attacks in Hereditary Angioedema patients. The stock had jumped over 1.88% to $5.14 in the last trading session.
    Borr Drilling Limited (BORR) is up more than 6.86% at $0.854 in pre-market hours Friday December 04, 2020. The stock had dropped over -1.78% to $0.80 in the last trading session.
    Before the trading started on December 04, 2020, Blink Charging Co. (BLNK) is up 4.14% to reach $23.64 after declaring an agreement with JSC Management Group, a large Burger King franchisee, to deploy numerous EV charging stations at key Burger King locations across the Northeast. It has been trading in a 52-week range of $1.25 to $34.67.
    Banco Santander S.A. (SAN) grew over 3.74% at $3.33 in pre-market trading today.
    Kandi Technologies Group Inc. (NASDAQ: KNDI) shares are trading up 2.98% at $8.3 at the time of writing. Company’s 52-week ranged between $2.17 to $17.45.
    InVivo Therapeutics Holdings Corp. (NVIV) lost over -4.67% at $0.6101 in pre-market trading Friday December 04, 2020.
    Aehr Test Systems (AEHR), a Semiconductor Equipment & Materials company, dropped about -8.74% at $1.88 in pre-market trading Friday after receiving $4.3 million order for initial FOX-XP™ test cell for production test of mobile sensor devices.
    ICICI Bank Limited (IBN) grew over 4.48% at $13.75 in pre-market trading today.
    NanoVibronix Inc. (NAOV) stock moved down -7.96 percent to $1.04 in the pre-market trading following the announcement of $6.0 million private placement.
    DocuSign Inc. (DOCU), a Software – Application company, rose about 4.43% at $241.25 in pre-market trading Friday.
    Dada Nexus Limited (DADA) is up more than 4.4% at $47.2 in pre-market hours Friday December 04, 2020 after reporting that Dada Now has partnered with dozens of cake chain brands across China, doubling the number of cooperating stores year-over-year as of November 2020. The stock had dropped over -15.65% to $45.21 in the last trading session.
    Salarius Pharmaceuticals Inc. (SLRX) stock moved up 1.85 percent to $1.1 in the pre-market trading.
    Auris Medical Holding Ltd. (NASDAQ: EARS) shares are trading down -3.23% at $3.3 at the time of writing after it pricing $8,000,000 common shares offering priced at-the-market. Company’s 52-week ranged between $0.65 to $6.60. Analysts have a consensus price target of $2.50.
    Acasti Pharma Inc. (ACST) lost over -2.94% at $0.33 in pre-market trading Friday December 04, 2020.
    Micro Focus International plc (MFGP) is up more than 6.3% at $6.07 in pre-market hours Friday December 04, 2020. The firm recently declared the findings of its ‘Endless Modernization’ research with Standish Group. The stock had jumped over 14.66% to $5.71 in the last trading session.
    BP p.l.c. (BP), a Oil & Gas Integrated company, rose about 4.54% at $22.33 in pre-market trading Friday.
    Tantech Holdings Ltd (NASDAQ: TANH) shares are trading up 4.27% at $1.71 at the time of writing after announcing the launch by its subsidiary, Shangchi Automobile Co., Ltd. (“Shangchi Automobile”), of its newest highly innovative driverless and autonomous street sweeper. Company’s 52-week ranged between $0.81 to $3.65.
    Trine Acquisition Corp. (TRNE) gained over 7.05% at $15.49 in pre-market trading Friday December 04, 2020.
    Enlivex Therapeutics Ltd. (ENLV) grew over 5.26% at $12.0 in pre-market trading today after reporting positive interim results of an investigator-initiated Phase II clinical trial evaluating AllocetraTM in severe and critical COVID-19 patients.

  • 49 Stocks Making Sharp Moves in Pre Market Session

    49 Stocks Making Sharp Moves in Pre Market Session

    BlackBerry Limited (BB) stock soared 21.29% to $8.49 in the pre-market trading following the announcement of its multi-year, global agreement with Amazon Web Services, Inc. (AWS). The most recent rating by TD Securities, on April 01, 2020, is a Hold.
    Gores Metropoulos Inc. (GMHI), a Shell Companies company, dropped about -3.71% at $16.37 in pre-market trading Wednesday.
    Carnival Corporation & Plc (NYSE: CCL) shares are trading up 2.48% at $20.65 at the time of writing. The firm recently reported Peter C. Anderson as a Section 16 Named Executive Officer. Company’s 52-week ranged between $7.80 to $51.94. Analysts have a consensus price target of $31.
    Guardion Health Sciences Inc. (GHSI) is up more than 2.11% at $0.3 in pre-market hours Wednesday December 02, 2020. The stock had jumped over 11.71% to $0.29 in the last trading session.
    Advaxis Inc. (ADXS) grew over 0.85% at $0.32 in pre-market trading today. The healthcare company recently announced closing of $9.2 million public offering.
    Before the trading started on December 02, 2020, RiceBran Technologies (RIBT) is down -5.56% to reach $0.68. It has been trading in a 52-week range of $0.37 to $2.43.
    Sundial Growers Inc. (SNDL) stock moved up 5.75 percent to $0.69 in the pre-market trading and the company recently announced elimination of senior secured second lien convertible notes.
    Kaixin Auto Holdings (KXIN) is up more than 4.55% at $7.35 in pre-market hours Wednesday December 02, 2020. The stock had jumped over 8.32% to $7.03 in the last trading session.
    Moleculin Biotech Inc. (MBRX) lost over -7.83% at $0.9125 in pre-market trading Wednesday December 02, 2020 after declaring that the US Food and Drug Administration (FDA) has approved its request for a “Rare Pediatric Disease” designation for its drug candidate WP1066.
    Jaguar Health Inc. (JAGX) stock plunged -5.83% to $0.4313 in the pre-market trading. The most recent rating by Rodman & Renshaw, on July 11, 2017, is a Buy.
    Auris Medical Holding Ltd. (EARS) stock plunged -17.97% to $4.29 in the pre-market trading after reporting positive efficacy data from testing AM-301 in vitro. The most recent rating by Euro Pacific Capital, on October 08, 2018, is a Buy.
    Before the trading started on December 02, 2020, Sunworks Inc. (SUNW) is up 9.88% to reach $4.67. It has been trading in a 52-week range of $0.29 to $8.50.
    China Automotive Systems Inc. (NASDAQ: CAAS) shares are trading down -4.95% at $8.25 at the time of writing after the firm declared that its shipped approximately 120,000 units from its portfolio of electric power steering products for use in Chinese electric vehicles during 2020. Company’s 52-week ranged between $1.42 to $10.50.
    Tilray Inc. (NASDAQ: TLRY) shares are trading up 1.61% at $8.2 at the time of writing. Company’s 52-week ranged between $2.43 to $22.95. Analysts have a consensus price target of $4.77.
    Ocugen Inc. (OCGN) lost over -8.87% at $0.3101 in pre-market trading Wednesday December 02, 2020. The company recently reported that leading independent proxy firms ISS and Glass Lewis recommended Ocugen stockholders vote “FOR” reverse stock split and authorized shares amendment proposals.
    AMC Entertainment Holdings Inc. (AMC) is up more than 2.41% at $4.25 in pre-market hours Wednesday December 02, 2020. The stock had dropped over -2.81% to $4.15 in the last trading session.
    Before the trading started on December 02, 2020, JetBlue Airways Corporation (JBLU) is down -4.67% to reach $14.7 following the declaration of its pricing of common stock offering. It has been trading in a 52-week range of $6.61 to $21.65.
    Before the trading started on December 02, 2020, Uxin Limited (UXIN) is down -3.65% to reach $1.32. It has been trading in a 52-week range of $0.72 to $3.10.
    Li Auto Inc. (NASDAQ: LI) shares are trading up 1.78% at $35.48 at the time of writing after announcing that the Company delivered 4,646 Li ONEs in November 2020. Company’s 52-week ranged between $14.31 to $47.70. Analysts have a consensus price target of $45.60.
    Aurora Cannabis Inc. (ACB) stock soared 3.59% to $10.1 in the pre-market trading. The most recent rating by Jefferies, on November 16, 2020, is an Underperform.
    Tantech Holdings Ltd (TANH), a Household & Personal Products company, dropped about -3.24% at $1.79 in pre-market trading Wednesday after reporting the launch by its subsidiary, Shangchi Automobile Co., Ltd., of its newest highly innovative driverless and autonomous street sweeper.
    Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) shares are trading down -5.52% at $1.37 at the time of writing. Company’s 52-week ranged between $0.91 to $9.78. Analysts have a consensus price target of $3.
    iBio Inc. (IBIO) is up more than 19.31% at $1.73 in pre-market hours Wednesday December 02, 2020 after revealing that it has entered into its first Statement of Work (“SoW”) under a Master Services Agreement with ATB Therapeutics to produce its bioengineered antibody-toxin fusion proteins using iBio’s FastPharming® System. The stock had dropped over -2.68% to $1.45 in the last trading session.
    Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) shares are trading up 2.09% at $23.42 at the time of writing. Company’s 52-week ranged between $7.03 to $59.78. Analysts have a consensus price target of $26.
    Moderna Inc. (MRNA) stock soared 6.09% to $149.6 in the pre-market trading. The biotechnology firm reported recently, that the primary efficacy analysis of the Phase 3 study of mRNA-1273 conducted on 196 cases confirms the high efficacy observed at the first interim analysis. The most recent rating by Wells Fargo, on November 23, 2020, is an Equal weight.
    Switchback Energy Acquisition Corporation (SBE) is down more than -4.16% at $28.13 in pre-market hours Wednesday December 02, 2020. The stock had dropped over -12.67% to $29.35 in the last trading session.
    Novavax Inc. (NVAX) grew over 4.84% at $129.44 in pre-market trading today after declaring COVID-19 vaccine clinical development progress.
    Before the trading started on December 02, 2020, Eastman Kodak Company (KODK) is up 3.88% to reach $7.5. It has been trading in a 52-week range of $1.50 to $60.00.
    ReneSola Ltd (SOL), a Solar company, dropped about -11.66% at $6.97 in pre-market trading Wednesday after releasing its third quarter 2020 financial results.
    Acasti Pharma Inc. (ACST) stock plunged -9.56% to $0.3301 in the pre-market trading. The most recent rating by Oppenheimer, on September 01, 2020, is a Perform.
    Pfizer Inc. (PFE) stock moved up 3.73 percent to $40.88 in the pre-market trading after the firm and BioNTech SE reporting that the Medicines & Healthcare Products Regulatory Agency (MHRA) in the U.K. has granted a temporary authorization for emergency use for their COVID-19 mRNA vaccine (BNT162b2), against COVID-19.
    Gevo Inc. (NASDAQ: GEVO) shares are trading down -3.17% at $1.83 at the time of writing. Company’s 52-week ranged between $0.46 to $2.91.
    Fisker Inc. (FSR) is down more than -3.41% at $17.55 in pre-market hours Wednesday December 02, 2020. The company recently reported that that Henrik Fisker, chairman and chief executive officer of Fisker, will participate in the Credit Suisse Eighth Annual Virtual Industrials Conference. The stock had dropped over -6.24% to $18.17 in the last trading session.
    Nxt-ID Inc. (NXTD) grew over 43.17% at $0.587 in pre-market trading today.
    Before the trading started on December 02, 2020, Bloom Energy Corporation (BE) is down -6.58% to reach $23.0 and the company will host virtual analyst day on December 16, 2020. It has been trading in a 52-week range of $3.00 to $28.24.
    Ocean Power Technologies Inc. (OPTT), a Electrical Equipment & Parts company, dropped about -3.54% at $2.45 in pre-market trading Wednesday.
    Nikola Corporation (NKLA) stock soared 4.38% to $18.13 in the pre-market trading after signing MOU with General Motors. The most recent rating by Loop Capital, on November 20, 2020, is a Buy.
    Vaxart Inc. (VXRT) gained over 3.92% at $7.95 in pre-market trading Wednesday December 02, 2020.
    salesforce.com inc. (CRM) lost over -4.16% at $231.3 in pre-market trading Wednesday December 02, 2020 after introducing service cloud workforce engagement to help contact centers thrive in an all-digital, work-from-anywhere world.
    InVivo Therapeutics Holdings Corp. (NVIV), a Biotechnology company, rose about 2.42% at $0.635 in pre-market trading Wednesday.
    FuelCell Energy Inc. (FCEL) stock plunged -20.11% to $7.23 in the pre-market trading following the publication pricing of its underwritten public offering of 34,518,539 shares of its common stock, at a public offering price of $6.50 per share. The most recent rating by JP Morgan, on November 19, 2020, is a Neutral.
    Pershing Square Tontine Holdings Ltd. (PSTH), a Shell Companies company, rose about 2.34% at $26.25 in pre-market trading Wednesday.
    Virgin Galactic Holdings Inc. (NYSE: SPCE) shares are trading up 4.37% at $29.59 at the time of writing after reporting its new flight window since it paused the spaceflight preparations in response to state guidelines from the New Mexico Department of Health to reduce the spread of COVID-19. Company’s 52-week ranged between $7.14 to $42.49. Analysts have a consensus price target of $19.
    Second Sight Medical Products Inc. (EYES) stock moved down -8.0 percent to $1.38 in the pre-market trading.
    BioNTech SE (BNTX) grew over 7.36% at $122.4 in pre-market trading today after declaring that it will hold a press conference including a video webcast on Wednesday, December 2, 2020, to provide an update on the status of the COVID-19 vaccine development program of its lead vaccine candidate BNT162b2.
    Sogou Inc. (SOGO), a Internet Content & Information company, rose about 3.09% at $8.68 in pre-market trading Wednesday.
    Tellurian Inc. (TELL) is down more than -4.29% at $1.56 in pre-market hours Wednesday December 02, 2020 and the firm recently declared the appointment veteran CEO and adds industry experts to board of directors. The stock had jumped over 9.40% to $1.63 in the last trading session.
    Arlo Technologies Inc. (ARLO) lost over -3.48% at $6.66 in pre-market trading Wednesday December 02, 2020.
    Before the trading started on December 02, 2020, ZoomInfo Technologies Inc. (ZI) is down -3.57% to reach $46.22 as the firm announced pricing of secondary offering of shares of class a common stock. It has been trading in a 52-week range of $30.83 to $64.40.

  • iBio, Inc. ( IBIO) rising above the horizon at the aftermarket trading

    iBio, Inc. ( IBIO) rising above the horizon at the aftermarket trading

    A biotech innovative and manufacturing company, iBio, Inc. (NYSE: IBIO) shares soared 17.93% in the aftermarket trading on Tuesday, December 1, 2020, after the company officially announced that it has entered into its first declaration of work to manufacture its bioengineered antibody-toxin fusion proteins using the FastPharming Method of iBio under a Master Services Arrangement with Belgium-based ATB Therapeutics.

    The fusion proteins, or atbodies, are engineered to treat cancers. A production process and assays for selected atbodies per the SoW will be designed by iBio.

    Tom Isett, Chairman & CEO of iBio, said that we are delighted to be selected as the process growth and distribution partner for atbtherapeutics, whose platform technology provides a novel solution to hard-to-treat haematological malignancies and solid tumors.